Medical Journal Articles | Grace Gawler Media

Game-changing Cancer Breakthrough Keytruda | New immunotherapy drug now FDA approved Grace Gawler

Because of the immune system’s extraordinary power, its capacity for memory, its exquisite specificity, and its central and universal role in human biology, these immunotherapy treatments have the potential to achieve complete, long-lasting remissions and cancer cures, with few or no side effects, and for any cancer patient, regardless of their cancer type. ( CRI )

The Immune System and Cancer Control: Exciting Developments in the USA and at QIMR Berghofer Brisbane Australia…..

Keytruda (pembrolizumab) is made by the drug company Merck. The drug belongs to a class of immunotherapies called checkpoint inhibitors. These drugs “take the brakes off” the immune response to cancer. They represent the most promising new cancer therapies to emerge in decades. Merck’s drug is the first FDA approved checkpoint inhibitor targeting a molecule called PD-1. The drug has been approved for the treatment of advanced or inoperable melanoma in patients who have failed prior treatment.

For 60 years, Cancer Research Institute (CRI) has been the pioneer in advancing this highly promising new class of treatment. Because of this investment, cancer immunotherapy today is a highly active and exciting field, with unprecedented potential to deliver on the decades-long promise of discovering, developing, and delivering safe and effective treatments that make a meaningful difference in the lives of patients fighting the disease. For those living in the USA – if you want more information about checkpoint inhibitors and immunotherapies.

To Join a webinar presented by Cancer Research Institute – “Immunotherapy: The Future of Prostate Cancer is Here” with Dr Charles Drake MD PhD September 30, 2014 at 2 pm ( please remember – New York time!) CLICK HERE

Please visit: www.cancerresearch.org for more more information about immunotherapy trials and treatments in USA.

Also visit: http://www.theanswertocancer.org

In Queensland – Australia – QIMR Berghofer Medical Institute Brisbane is dedicated to translating discoveries into treatments, diagnostics and prevention strategies.

Listen to this interview with Sara-Jane who was a guest on Navigating the Cancer Maze Radio this week. Sara Jane is from QIMR Berghofer Medical Research Institute. She will speak about the Research Roadshow and other aspects of this research centre. Learn how you can get involved and benefit.

To discover what is being researched at QIMR visit their website by CLICKING HERE:

In Next blog:

More on the Research Roadshow at QIMR Berghofer and Record keeping – so important for any cancer patient. I look at some creative ways to keep your medical records in order.

Until next time

Grace

Grace Gawler|The story of a bionic woman in Global Health and Travel Magazine

Maya Angelou said: “You may not control all the events that happen to you, but you can decide not to be reduced by them.” Global Health and Travel Magazine recently published an edition (July-Aug 2014) featuring women who are exceptional survivors and who were not reduced by events out of their control! Grace Gawler speaks with Global health and Travel Magazine.

Maya Angelou said: “You may not control all the events that happen to you, but you can decide not to be reduced by them.”

Global Health and Travel Magazine recently published an edition (July-Aug 2014) featuring women who are exceptional survivors and who were not reduced by events out of their control!

Women of Substance – Asia’s Leading Ladies in Healthcare – Female Patients and their success stories. The July-August 2014
Global Health and Travel Magazine features stories of 5 women who overcame the odds to survive and thrive.

I am honoured to be one of the 5 women they featured and it goes without saying that a Dutch surgeon, Dr Rudd Schouten ( 2002) and 2 Singaporean surgeons, Dr Francis Seow Choen and Dr Lim Jit Fong (2009), from Fortis Surgical Hospital, Singapore, were also major players. A team effort for survival. I am forever grateful to them for humanity & surgical skill.

You will read how life sometimes throws us a curve ball…… just when everything appears to be going smoothly! Mine came in 1997 when my 21 marriage ended suddenly. Three days later, another blow; a total prolapse of my uterus changed my life direction even more. A surgical procedure aimed at repair and health restoration saw the unthinkable happen – Complications left me without bowel function. As you can imagine if you have ever been constipated for a few days…..the consequences were horrendous and over time, large sections of impacted colon had to be surgically removed.

This part of my story has also been recorded in my Memoirs Grace Grit and Gratitude.( pub 2008) Copies available eBook, soft cover or Click here to read on Google books. This is a free read. Section 39 talks about my Bionic surgery.

I hope that the inclusion of my survival story in Global Health and Travel magazine, inspires others to take a chance and walk in the field of all possibilities. In 2002 – 2003 I underwent experimental surgery ( InterStim Therapy) that would enable me to have another chance at Life! If you would like more information or to explore InterStim Therapy and if it is applicable to you – Please contact me via the contact page on this blog.

To read the full story – Global Health and Travel can be purchased online as a Single Digital Issue or by yearly subscription. This is a high quality health information magazine for any person who is consciously making efforts to improve their health and wellbeing and who wants to be informed.

Click here for sample or to purchase online subscription to

Global Health and Travel is worthy of a subscription. It is a premier resource on medical tourism as well as providing articles about general healthcare. The magazine focuses on services offered by internationally-accredited healthcare institutions typically sought by travellers including complex, specialized procedures such as joint replacement for hips and knees, cardiac surgery, fertility treatment and more. Combined with vibrant and informative stories on beauty, travel, health and wellbeing, Global Health and Travel is your reliable guide to healthcare abroad. The latest edition is a great read if you want to know more about immunology.

To read the story – Select below then enlarge text via magnifier.

Introducing Health Intelligence Australia-A new Model of Healthcare Grace Gawler and Dr Bruce Whelan

On this week’s Navigating the Cancer Maze on Voice America radio, I presented an encore broadcast of a special interview with my colleague GP Dr Bruce Whelan: “Spinning Gold from Straw: How trauma transformed a Doctor’s Life and Practice”. This year, Dr Whelan and I have forged a very special medical partnership to help patients Navigate the Cancer Maze – Health Intelligence Australia.

On this week’s Navigating the Cancer Maze on Voice America radio, I presented an encore broadcast of a special interview with my colleague GP Dr Bruce Whelan: “Spinning Gold from Straw: How trauma transformed a Doctor’s Life and Practice”. This year, Dr Whelan and I have forged a very special medical partnership to help patients Navigate the Cancer Maze – Health Intelligence Australia.

Last week a patient asked me what makes Dr. Bruce Whelan unique in terms of the type of medicine he practises? The answer came

easily. In the past 10 years Bruce has become involved with and specialized in management of addictions, mental health and severe and chronic pain as well as general medicine. These are also all important aspects of cancer management. They are the areas of medicine that tend to be under-serviced by GPs due to time constraints or lack of training. But there is more that makes Dr Bruce Whelan uniquely suited to the new Health Intelligence Australia group.

Another area of Dr Bruce Whelan’s expertise is in the area of trauma. He knows a lot about trauma at a very personal level because in 2002 he was summoned to Bali from Sri Lanka, where he was working. He was given the unspeakably grim task of identifying bodies after the bombing at the Sari Club in Bali. His task was made even worse when he spent two days unsuccessfully trying to find and identify the body of his son-in-law Shane – killed in the bombing along with a partner of his daughter’s friend. As luck had it the girls were going to be late getting to the Sari Club that night. But lucky as they were to escape; the trauma of the incident lived on and shaped their future.

When Bruce graduated from the University of Queensland in 1967, like many of us, he had no idea what life had in store for him. As a doctor, Bruce Whelan had already seen lot of suffering, but the post-traumatic stress affect that the Bali incident produced, had long lasting effects. The product of uninvited change! Bruce fought a battle he could not win; to have bodies quickly identified, stored appropriately and repatriated to Australia.

This intensified the trauma, grief and loss experienced by many. However, being a resourceful doctor, eventually he was able to spin gold from straw as they say, and today, 14 years later; the experience brings with it a man who is the wounded healer who serves his patients with a rare quality of directness and authenticity. He is someone who deeply understands trauma and depression in another human being.

There is no substitute for this type of life experience. This type of experience can’t be learned in any university except in the university of life!

It is recognized by psycho-oncologists that a diagnosis of cancer is also a traumatic event and many patients experience PTSD (post traumatic stress disorder) that often remains undiagnosed and untreated throughout the course of the illness. Some patients have experienced trauma before diagnosis and it may not have been dealt with. Unrecognized trauma can play a complicated role in the ongoing management of illness. Major life traumas can impact every treatment approach that a cancer patient will try during their recovery….. it can even affect patients who are survivors of the physical illness, but who did not have the opportunity to deal with the psychological impact of the illness at the time. This often plays out as depression, memory loss or dissociative disorders.

To make an appointment for a consultation to see either myself or Dr Whelan, or for a team consultation, please visit:

http://www.healthintelligenceaustralia.com/make-an-appointment/ or call 1800 011 723

RESOURCES: Check out the following resources to understand more about PTSD and the brain:The Biology of Trauma http://www.natal.org.il/english/?CategoryID=232

Article Psychology Today: The Anatomy of Post traumatic Stress Disorder

Listen to interviews with Dr Bruce Whelan on Voice America – at http://www.drbrucewhelan.com/about-dr-bruce/

Navigating the Immune System | The Key to Future Cancer Therapies

Today on Voice America’s Navigating the Cancer Maze, I interview Professor Mark Smyth who is regarded as an international leader in tumour immunology, immunotherapy and natural killer (NK) cell biology. My co-host is Dr Bruce Whelan, GP.We are nk-cells-(green)-attack-diseased-human-cellsaware there is a great need for cancer education in the community. By understanding the intricacies of the immune system in parallel with the biological nature of cancer; we believe that patients will make better informed decisions regarding their choice of cancer treatment.

Today on Voice America’s Navigating the Cancer Maze, I interview Professor Mark Smyth who is regarded as an international leader in tumour immunology, immunotherapy and natural killer (NK) cell biology. My co-host is Dr Bruce Whelan, GP.

Episode Description

Today I interview Professor Mark Smyth who is regarded as an international leader in tumour immunology, immunotherapy and natural killer (NK) cell biology. My co-host is Dr Bruce Whelan, GP. Dr Whelan and I see cancer patients in our practices.

We are aware there is a great need for cancer education in the community. By understanding the intricacies of the immune system in parallel with the biological nature of cancer; we believe that patients will make better informed decisions regarding their choice of cancer treatmentProfessor Smyth is a person of influence who has made key discoveries in his field.

A number of those discoveries have led to new clinical trials in cancer immunotherapy. Professor Smyth relocated to the QIMR Berghofer in Brisbane (2013) as Senior Scientist and NH&MRC Australia Fellow.

He is a Senior Editor at Cancer Research, & a member of the Scientific Advisory Board of the Cancer Research Institute (USA).

Learn More: www.qimrberghofer.edu.au

Professor Mark Smyth

Professor Mark Smyth received his PhD from the University of Melbourne in 1988 & trained at the National Cancer Institute (USA) 1988-1992.

After 8 years at Austin Research Institute Melbourne, working on mechanisms of lymphocyte-mediated cytotoxicity, he relocated to Peter Macallum where his studies on effector molecules collectively rekindled world-wide interest in cancer immune surveillance. A number of his discoveries have led to new clinical trials in cancer immunotherapy.

Professor Smyth relocated to QIMR Berghofer, Brisbane (2013) as a Senior Scientist and NH&MRC Australia Fellow. He is a Senior Editor at Cancer Research, and a member of the Scientific Advisory Board of the Cancer Research Institute (USA).

Summary

The Immunology in Cancer and Infection Laboratory currently focuses upon advancing our understanding of the basic principles underlying an immune response to cancer and infection.

A Natural Killer cell (yellow) attacks a cancer cell. The NK cell reaches out and delivers the “kiss of death.” — A Natural Killer cell (yellow) attacks a cancer cell.
The NK cell reaches out and delivers the “kiss of death.”

We aim to further understand these processes at the molecular level, with particular emphasis on the role of the innate immune system, in particular, NK cells, NKT cells and gamma-delta T cells.

Our laboratory is building a detailed picture of how networks of immune cells function to recognise, respond to, and destroy tumour cell masses and metastases. We are interested in defining the importance, timing, and nature of the natural immune response to transformation.

We are also using new antigens (including glycolipids), antibodies, and cytokines in combination to stimulate strong innate and lasting adaptive immunity to cancer.

Our findings are being used to develop more effective biological and cellular therapies for human cancer, in particular, melanoma, breast and prostate cancer, and haematological cancers.

Learn more about Prof Smyth’s research

at http://www.qimrberghofer.edu.au/page/Lab/Immunology_Cancer_Infection

One of QIMR Berghofer’s three Research Programs is cancer, one of the major causes of illness and death in Australia and the developed world. In 2012, it is estimated that more than 120,700 Australians were diagnosed with cancer (excluding non-melanoma skin cancer). Cancer accounted for about 3 in 10 deaths in Australia, making it the second most common cause of death, exceeded only by cardiovascular diseases. Cancer is a disease which is caused by abnormal cell growth and eventually spreads to other parts of the body. Some cancers are common within a family history and are clearly inherited, while others are caused by factors in the environment interacting with genetic susceptibilities. Many forms of cancer can be treated successfully if detected early.

Cancer types researched by QIMR Berghofer Medical Research Institute

Blood cancers (including leukaemia, lymphoma and myelomas)
Brain cancer (glioblastoma)
Breast cancer
Colorectal (bowel) cancer
Endometrial cancer
Lung cancer
Melanoma
Multiple endocrine neoplasia type 1 (endocrine cancer)
Nasopharyngeal carcinoma (nose and throat cancer)
Non-melanoma skin cancer (actinic solar keratosis, squamous cell carcinoma, basal cell carcinoma)
Oesophageal cancer (including Barrett’s oesophagus)
Ovarian cancer
Pancreatic cancer
Prostate cancer
Stomach (gastric) cancer

Learn More: www.qimrberghofer.edu.au Navigating the Cancer Maze is presented by the Grace Gawler Institute for Integrated Cancer Solutions, Gold Coast Australia. We are a not for profit health promotion charity.

Why Immunotherapy Month has been a Symbol of Hope for Cancer Patients | Grace Gawler

This week on Navigating the Cancer Maze I re-presented an interview with Dr Horst Lindhofer PhD, Munich, Germany who was the creator of Tri-Functional antibodies. In the last segment – I provide an overview and more resources plus coming events for those who live in or near Brisbane.

http://www.qimrberghofer.edu.au Interview links:

www.trionresearch.de OR www.neoviibiotech.com/contact.html

Immunotherapy is not new. It is interesting to take a look at the History of Immunotherapy and it’s pioneers.

In the 1850s, doctors in Germany noticed that patients’ tumours would occasionally shrink if their tumour became infected. This observation led to the idea that the body’s immune system could be harnessed and made to fight cancer.

Around the same time, doctors throughout Europe, encouraged by the success of Edward Jenner’s smallpox vaccine, attempted to make a ‘cancer vaccine’ by injecting patients with crude extracts of tumours from other cancer patients. These treatments were largely ineffective, but the field of ‘immunotherapy’ was born.

Initial progress on immunotherapy was slow, and over a hundred years’ work in the laboratory yielded little success in actual cancer treatment. This all changed when in 1975, Georges Köhler and César Milstein, working in Cambridge, discovered how to make synthetic antibodies.

Their discovery, coupled with an ever-increasing understanding of the immune system, has led to a variety of treatments and strategies that use the immune system to tackle cancer. Some, such as the antibody-based breast cancer drug Herceptin, are now used routinely to treat cancer patients.

Professor Jérôme Galon, Ph.D. whom I recently interviewed on Navigating the Cancer Maze received the William B. Coley Award in 2010. The award was established in 1975 in honor of Dr. William B. Coley, a pioneer of cancer immunotherapy, whose daughter, Helen Coley Nauts, founded Cancer Research Institute. To understand Immunotherapy – please take 7 minutes to view this excellent video:

Immunotherapy: Boosting the immune system to fight cancer

[youtube https://www.youtube.com/watch?v=-NNjDjXSJt0]

William B. Coley, in 1891, injected streptococcal organisms into a patient with inoperable cancer. He thought that the infection he produced would have the side effect of shrinking the malignant tumor. He was successful, and this was one of the first examples of immunotherapy. Over the next forty years, as head of the Bone Tumor Service at Memorial Hospital in New York, Coley injected more than 1000 cancer patients with bacteria or bacterial products. These products became known as Coley’s Toxins. He and other doctors who used them reported excellent results, especially in bone and soft-tissue sarcomas.

Despite his reported good results, Coley’s Toxins came under a great deal of criticism because many doctors did not believe his results. This criticism, along with the development of radiation therapy and chemotherapy, caused Coley’s Toxins to gradually disappear from use. However, the modern science of immunology has shown that Coley’s principles were correct and that some cancers are sensitive to an enhanced immune system. Because research is very active in this field, William B. Coley, a bone sarcoma surgeon, deserves the title “Father of Immunotherapy.”

Further acceptance of his ideas was brought about by Coley’s own children. His son Bradley (1892-1961), also an orthopaedic surgeon, succeeded him as the head of the Bone Tumor Service at Memorial Hospital. Bradley Coley’s major textbook on bone tumors was published in 1948, and while advocating surgery as the main treatment for bone sarcomas, he supported the use of Coley’s toxin as adjunctive therapy. He believed that it would be of value in preventing micro-metastasis. His daughter, Helen Coley Nauts (1907-2001), became a cancer researcher and devoted her life to the study of her father’s toxins. She tabulated every patient he treated and reviewed all his notes. She published 18 monographs and tabulated over 1000 of his cases and noticed that in 500 of these there was near-complete regression. She founded Cancer Research Institute in New York.

Read stories of patients successes immunotherapy trials from Cancer Research Institute at: Select from the menu ‘Who is the Immunocommunity’ and select the drop down menu ‘Patients Stories’

http://www.theanswertocancer.org/

Immunotherapy can be local or systemic.

Local immunotherapy delivers the treatment to the affected area. For example, the BCG vaccine can be injected into the bladder to treat bladder cancer, as it causes inflammation that can cause the tumour to shrink.

Systemic therapy treats the whole body and is useful for targeting cancer that may have spread. In the 1980s, scientists at the Cancer Research UK Medical Oncology Unit at the Christie Hospital in Manchester showed that the protein interferon alpha could cause tumours to shrink in patients with low-grade lymphoma. Interferon is now used to treat several different types of cancer.

Immunotherapy can also be non-specific or targeted.

Non-specific immunotherapy works by boosting the body’s immune system in general, so that its natural cancer-killing activity is enhanced. Both of the examples of local and systemic therapies (above) are also examples of non-specific immunotherapy.

Targeted immunotherapy is designed to make the immune system specifically kill cancer cells. The following types of targeted immunotherapy are available or are in development:

Antibody-based therapies

Antibodies are proteins produced by the immune system. A type of white blood cell called a B-cell produces them in response to an infection. Normally, antibodies stick to foreign objects in the body and label them for destruction. Researchers have been trying to make antibodies that will attach themselves only to cancer cells. This can be useful in four ways.

It can stop the cancer from growing by stopping other essential ‘growth factors’ from sticking to it.
It can ‘tag’ the cancer for destruction by the immune system.
If cancer drugs or radioactive particles are attached to the antibody, it can deliver them directly to the cancer cell without harming the rest of your body.
An enzyme (a type of protein that can promote chemical reactions) can be attached to an antibody, and then given to a patient along with a chemical that can be turned into a powerful drug by the enzyme. This directs the drug to the cancer, and minimise side effects. This process is known as Antibody-directed Enzyme/Pro-drug Therapy (ADEPT).

Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1888599/

http://www.cancerresearchuk.org/

http://www.cancerresearch.org

http://www.qimrberghofer.edu.au/

FOR MORE INFORMATION ABOUT IMMUNO-THERAPY already available in Germany for Clinical use – please contact me via the contact form on this blog or email to my new email address for enquiries: germancancertreatments@gmail.com

How our immune System Fights Cancer|Knowledge to Help you Navigate the Cancer Maze Grace Gawler & Prof Jerome Galon

Do want to get some insights into the intricate working of your immune system? Navigating the Cancer Maze, Grace Gawler interviews Prof. Dr. Jerome Galon: Research Director at INSERM (National Institute of Health and Medical Research) & leader of the INSERM Integrative Cancer Immunology laboratory, at the Cordeliers Research Centre, Paris, France.

Do want to get some insights into the intricate working of your immune system and cancer? On Navigating the Cancer Maze, internet radio Grace Gawler interviews Prof. Dr. Jerome Galon: Research Director at INSERM (National Institute of Health and Medical Research) & leader of the INSERM Integrative Cancer Immunology laboratory, at the Cordeliers Research Centre, Paris, France.

Listen to the show by selecting the following link:

http://www.voiceamerica.com/episode/78656/how-our-immune-system-fights-cancer-knowledge-to-help-you-navigate-the-cancer-maze

Professor Galon’s current interests & major contributions concern basic & translational research in cancer immunology, using systems biology.

His laboratory has made some ground-breaking findings demonstrating that the adaptive immune response within a tumor was a better predictor of survival than traditional staging based on the size and spread of a tumor.The new wave of immunotherapies reflects what has been known for some time; that the answer to cancer is in you! But it is not that simple. Our immune system is complex and intricate & as science unravels its mysteries, we are developing new understandings of how the immune system can be captured & recruited in the laboratory; retrained and returned to you the patient!

Awards: In 2008 Prof Dr Galon was awarded The Colon Cancer Research Schaeverbeke Award, Fondation de France,& the Clinical Research Award, Rose Lamarca, Fondation pour la Recherche Médicale.

INSERM UMRS1138 Laboratory of Integrative Cancer Immunology (Team 15) Cordeliers Research Center 15 Rue de l'Ecole de Medecine 75006 Paris, France — INSERM
Laboratory of Prof Jerome Galon Integrative Cancer Immunology (Team 15)
Cordeliers Research Center

In 2010 he received the William B. Coley Award from the Cancer Research Institute, NY, USA, 2011: the French National Academy of Science & the French National Academy of Medicine (2011) awards.

He has published many scientific papers and book chapters.

Health professionals and interested patients;

Visit INSERM UMRS 1138
Cordeliers Research Center
at http://www.ici.upmc.fr/

For more about Integrative Cancer Immunology Laboratory and their research projects, Immunoscore, publications, seminars and links.

Health professionals – I especially recommend the Publications page and homepage side bar at INSERM’s website.

Prof Galon was a guest of QIMR Berghofer Medical Research Institute, Brisbane Qld , Australia. See their website at http://www.qimrberghofer.edu.au/

To listen to the audio – live streaming log on to the URL below. You can download this and other interviews with cancer experts at:

http://www.voiceamerica.com/episode/78656/how-our-immune-system-fights-cancer-knowledge-to-help-you-navigate-the-cancer-maze

To be continued……..

Enjoy the weekend….Grace

How Your Body Can Fight Cancer – Immunotherapies are on their way Grace Gawler with Professor Rajiv Khanna

How Your Body Can Fight Cancer – Immunotherapies are on their way! QIMR Brisbane is celebrating their cancer research findings by hosting a series of immunology presentations during Immunotherapy Week, June 15 – June 21 2014. Special Guest speaker will be Professor Jérôme Galon, Cordelier Research Center, Paris, France whose topic is “Cancer cure may be inside you and unleashed by immunotherapy”. To bring public awareness to Immunotherapy Week at the QIMR Berghofer Medical Research Institute, Brisbane Professor Rajiv Khanna Director of immunotherapy and vaccine development was interviewed on Navigating the Cancer Maze radio this week to publicize the need to bring research findings and medical trials into public awareness.

How Your Body Can Fight Cancer – Immunotherapies are on their way!

QIMR Brisbane is celebrating their cancer research findings by hosting a series of immunology presentations during Immunotherapy Week, June 15 – June 21 2014. Special Guest speaker will be Professor Jérôme Galon, Cordelier Research Center, Paris, France whose topic is “Cancer cure may be inside you and unleashed by immunotherapy”.

To bring public awareness to Immunotherapy Week at the QIMR Berghofer Medical Research Institute, Brisbane Professor Rajiv Khanna Director of immunotherapy and vaccine development was interviewed on Navigating the Cancer Maze radio this week to publicize the need to bring research findings and medical trials into public awareness. In particular he discusses his breakthrough immunotherapy research on Glioblastoma Multiforme.

As well on Navigating the Cancer Maze, Prof Khanna also discusses his research and clinical trial results on nasopharyngeal carcinoma, an aggressive throat cancer that has has shown response to immune therapies.

Image: Above – Cancer researcher Professor Rajiv Khanna, pictured with patient Eddie Chen, has developed a promising new treatment. Picture: Annette Dew Source: The Courier-Mail.

CLICK HERE to read Janelle Miles Courier Mail article – ‘Queensland Institute of Medical Research scientist Rajiv Khanna unveils promising new treatment for aggressive throat cancer’ published FEBRUARY 02, 2012

To listen to this very interesting and highly informative audio interview or to download on itunes (both free of charge), visit the link below direct to voice America and my show webpage.

http://www.voiceamerica.com/episode/78495/navigating-the-brain-cancer-maze-promising-results-from-world-first-brain-cancer-trials

Promising Results from World-First Brain Cancer Trials Professor Rajiv Khanna | Grace Gawler on Navigating The Cancer Maze

It is imperative that breakthroughs in cancer treatments are known to the world. Worldwide, there are an estimated 240,000 cases of brain and nervous system tumors diagnosed each year; GBM is the most common, and the most lethal of these tumors. People speak of the War on Cancer, but it is our bodies that are at war with cancer cells via our immune system and its responses. Utilizing the immune system principle, scientists at the QIMR Berghofer Medical Research Institute, Australia, have used immunotherapy to create a major breakthrough in the treatment of the brain cancer known as Glioblastoma Multiforme (GBM).

Free informational cancer seminars Brisbane June 15 – 21 2014 Brisbane.

Click the link below to see other events presented by QIMR – for immunology week June 15 – 21 2014 Brisbane.

How your body can fight cancer Seminars

Promising Results from World-First Brain Cancer Trials Professor Rajiv Khanna Joins Grace Gawler on Navigating The Cancer Maze To Talk about a Brain Cancer breakthrough.

Phoenix, AZ — 06/13/2014 — Voice America Talk Radio Network, Internet broadcasting pioneer, producing and syndicating online audio and video, today announced that Professor Rajiv Khanna QIMR Berghofer Medical Research Institute Australia will join Grace Gawler host of Navigating the Cancer Maze program on the VoiceAmerica Health and Wellness Channel (http://www.voiceamerica.com/show/2125/navigating-the-cancer-maze) Friday, June 13, 2014 at 12 noon Pacific Time.

NOTE: show goes live to air 5 am Brisbane Australia time Saturday 14 June 2014. Available streaming audio any time after 9 am this Saturday and available to download on itunes indefinitely.

It is imperative that breakthroughs in cancer treatments are known to the world. Worldwide, there are an estimated 240,000 cases of brain and nervous system tumors diagnosed each year; GBM is the most common, and the most lethal of these tumors. People speak of the War on Cancer, but it is our bodies that are at war with cancer cells via our immune system and its responses. Utilizing the immune system principle, scientists at the QIMR Berghofer Medical Research Institute, Australia, have used immunotherapy to create a major breakthrough in the treatment of the brain cancer known as Glioblastoma Multiforme (GBM). Study leader, Professor Rajiv Khanna, said most of the study participants lived much longer than the six-month prognosis normally given to a patient with recurrent GBM, and some patients showed no signs of disease progression. “It is early days, but this is exciting,” Professor Khanna said.

“Survival rates for this aggressive cancer have barely changed in decades. There is an urgent clinical need for new treatments. “If this treatment can buy patients more time, then that is a big step forward.”

GBM is the most common malignant brain cancer, diagnosed in about 800 Australians every year. Despite surgery, radiotherapy and chemotherapy, less than 10% of patients survive beyond five years. This study built on previous research which found that many brain tumours carry cytomegalovirus (CMV). About half of all Australians have the virus, but usually show no symptoms.

Professor Khanna developed a technique to modify the patients’ T-cells in the laboratory, effectively “train” them to attack the virus, and then return them to the patient’s body. When the killer T-cells destroyed the virus, they also destroyed the cancer. “It’s becoming increasingly clear that immunotherapy – manipulating a person’s own immune system – is a rich new frontier for cancer treatment,” Professor Khanna said.

The QIMR is celebrating their research findings by hosting a series of immunology and cancer presentations between June 15 and June 21 in Brisbane. For those people who cannot attend, watch out on the websites for more information. www.qimrberghofer.edu.au or www.gracegawlermedia.com

The Phase I trials were conducted at Brisbane’s Wesley Hospital, under the leadership of neurosurgeon Professor David Walker. “Working with patients with malignant brain tumors can be distressing, because we know so many will succumb,” Professor Walker said. “But this new branch of therapy lets us offer some hope that the future is going to be brighter, that new and innovative treatments mean things will hopefully improve in the future. “We have a long way to go, and there is hard work to be done, but we seem to be on the right track, and it is a pleasure to work with scientists at QIMR Berghofer to try to make a real difference.”

The research team is now keen to begin the next phase of trials, involving patients at an earlier stage of the cancer’s development. “These would be patients who have just been diagnosed and are about to start the standard treatments – surgery, then radiotherapy or chemotherapy. We would generate the T cell therapy before their standard treatment, and then administer T cells in conjunction with the standard therapy,” Professor Khanna said.

“We hope that the treatment can be even more effective if given at an earlier stage of the disease.”

This study is published online in the prestigious US journal Cancer Research and can be viewed at http://cancerres.aacrjournals.org/content/early/recent

The research was funded by Flagship Funding from the Rio Tinto Ride to Conquer Cancer, the NHMRC and private donors.

The QIMR Berghofer Medical Research Institute is a world leading translational research institute focused on cancer, infectious diseases, mental health and a range of complex diseases. Working in close collaboration with clinicians and other research institutes, our aim is to improve health by developing new diagnostics, better treatments and prevention strategies.

For more information about QIMR Berghofer Visit: www.qimrberghofer.edu.au

Immunology and Cancer Survival | Navigating the Cancer Maze| Grace Gawler

QIMR Berghofer Medical Research Institute is hosting Immunotherapy week: Get updated about Immunotherapies. Next week QIMR presents a series of lectures about the latest developments in Cancer Immune therapies. QIMR’s Professor Khanna, has been researching immunotherapies and has had a major breakthrough in the treatment of the aggressive brain cancer Glioblastoma Multiforme (GBM).

ATTENTION Queenslanders interested in immune-based Cancer Therapies: Cancer Immunotherapy Week Brisbane

QIMR Berghofer Medical Research Institute is hosting Immunotherapy week: Get updated about Immunotherapies. Next week QIMR presents a series of lectures about the latest developments in Cancer Immune therapies.

Scientists at the QIMR Berghofer Medical Research Institute have used immunotherapy to make a major breakthrough in the treatment of the aggressive brain cancer Glioblastoma Multiforme (GBM). There will be a presentation on Tuesday evening and other presentations throughout the week.

CLICK HERE FOR MORE INFORMATION

Later this week on Navigating the Cancer Maze I will be interviewing…Professor Rajiv Khanna a leading researcher at The QIMR Berghofer Medical Research Institute, Brisbane, Australia; a world progressive translational research institute focused on cancer, infectious diseases, mental health and a range of complex diseases. Professor Khanna has been researching immunotherapies and has had a major breakthrough in the treatment of the aggressive brain cancer Glioblastoma Multiforme (GBM). Professor Khanna developed a technique to modify the patients’ T-cells in the laboratory, effectively “train” them to attack the virus, and then return them to the patient’s body. When the killer T-cells destroyed the virus, they also destroyed the cancer. “It’s becoming increasingly clear that immunotherapy – manipulating a person’s own immune system – is a rich new frontier for cancer treatment,” Professor Khanna said. Be informed about the answer to cancer. Support Immunotherapy week- Brisbane Qld. More info at http://www.qimrberghofer.edu.au/

All shows are available in the content Library at Navigating the Cancer Maze on The VoiceAmerica Variety Channel for on-demand and pod cast download. The Grace Gawler Institute is a not for profit health promotion charity providing global access to free information for cancer patients about the latest in cancer information and treatments from experts, patients, caregivers and researchers.

Visit: http://www.gracegawlerinstitute.com

Navigating the Cancer Maze | i am the answer to cancer |Cancer Immunotherapy Month

Navigating the Cancer Maze | i am the answer to cancer |Cancer Immunotherapy Month. Where is the answer to cancer? According to Jill O’Donnell-Tormey, Ph.D and the organization she represents,Cancer Research Institute (CRI); the answer is ‘i am the answer to cancer’; yes-the patients immune system holds the answer to cancer!

Navigating the Cancer Maze | i am the answer to cancer |Cancer Immunotherapy Month
June 6, 2014
Did you know that June is Cancer Immunotherapy Month? Tune in to Navigating the Cancer Maze for inspiring listening and learn about the good news – the Answer to Cancer

Dr. Jill O'Donnell-Tormey PhD CEO Cancer Research Institute NY — Dr. Jill O’Donnell-Tormey PhD CEO Cancer Research Institute NY

Where is the answer to cancer? According to my guest Jill O’Donnell-Tormey, Ph.D and the organization she represents,Cancer Research Institute (CRI); the answer is ‘i am the answer to cancer’; yes-the patients immune system holds the answer to cancer! Select link below to listen to audio

http://www.voiceamerica.com/episode/78363/navigating-the-cancer-maze-i-am-the-answer-to-cancer-cancer-immunotherapy-month

The CRI is a non-profit organization founded in 1953 & today’s global leader in supporting & coordinating research aimed at harnessing the immune system’s power to conquer all cancers. Jill will explain immunotherapy & its value to cancer patients as well as the different types of cancer immunotherapy available. There will be patient stories & an exploration of the very latest in immunotherapy. A New Cancer Immunotherapy Website for Patients and Caregivers was launched recently. Get on board with supporters like Olivia Newton John who recently lent public support to CRI. http://www.cancerresearch.org http://www.TheAnswerToCancer.org

Listen to Navigating the Cancer Maze 12 Noon Fridays – live from Arizona (PST) – Saturday Australia 5am free to air or download and listen later – available free download on itunes.

http://www.sbwire.com/press-releases/dr-jill-odonnell-tormey-phd-ceo-director-of-scientific-affairs-of-the-cancer-research-institute-ny-joins-grace-gawler-on-navigating-the-cancer-maze-to-talk-about-cancer-immunotherapy-month-516331.htm

LISTEN TO INTERVIEW: